Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 3, 2013, Pages

  Austin, Nicola ^a   Darlow, Brian A ^b   Mcguire, William ^c  

^a Christchurch Womens Hospital   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; MICONAZOLE; NYSTATIN; FLUCONAZOLE;

CAUSE OF DEATH; DECISION MAKING; EXTUBATION; EYE INFLAMMATION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFORMATION PROCESSING; INTENSIVE CARE UNIT; LIMIT OF QUANTITATION; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETINITIS; RETROLENTAL FIBROPLASIA; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; VERY LOW BIRTH WEIGHT; META ANALYSIS; MYCOSIS; NEWBORN; ORAL DRUG ADMINISTRATION; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MICONAZOLE; MYCOSES; NYSTATIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

MLCS; MLOWN;

EID: 84880077680     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003478.pub4     Document Type: Review

References (43)

1. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, et al.Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011;96(3):F164-8. [PUBMED: 20659937]
2. Aydemir C, Oguz SS, Dizdar EA, Akar M, Sarikabadayi YU, Saygan S, et al.Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011;96(3):F164-8. [PUBMED: 20659937]
3. Ozturk MA, Gunes T, Koklu E, Cetin N, Koc N. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. Mycoses 2006;49(6):484-92.
4. Sims ME, Yoo Y, You H, Salminen C, Walther FJ. Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. American Journal of Perinatology 1988;5(1):33-6.
5. Violaris K, Carbone T, Bateman D, Olawepo O, Doraiswamy B, LaCorte M. Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants. American Journal of Perinatology 2010;27(1):73-8. [PUBMED: 19504425]
6. Violaris K, Doraiswamy B, Olawepo O, Gulrajani-LaCorte M. Fluconazole versus nystatin prophylaxis for fungal infection in very low birth weight (VLBW) infants. Pediatric Research. 1998; Vol. 44:254A.
7. Wainer S, Cooper PA, Funk E, Bental RY, Sandler DA, Patel J. Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection. Pediatric Infectious Disease Journal 1992;11(9):713-6.
8. Damjanovic V, Connolly CM, van Saene HK, Cooke RW, Corkill JE, van Belkum A, van Velzen D. Selective decontamination with nystatin for control of a candida outbreak in a neonatal intensive care unit. Journal of Hospital Infection 1993;24(4):245-59.
9. Harris LJ. Further observations on a simple procedure to eliminate thrush from hospital nurseries. American Journal of Obstetrics and Gynecology 1960;80:30-1.
10. Herruzo-Cabrera R, Garcia Gonzalez JI, Garcia-Magan P, del Rey-Calero J. Nosocomial infection in a neonatal intensive care unit and its prevention with selective intestinal decolonization. A multivariant evaluation of infection reduction. European Journal of Epidemiology 1994;10(5):573-80.
11. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight Infants. Ongoing study February 2012.
12. Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003850.pub3]
13. Benjamin DK Jr, Poole C, Steibach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112(3 Pt 1):634-40.
14. Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al.Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117(1):84-92.
15. Brecht, M, Clerihew, L, McGuire, W . Prevention and treatment of invasive fungal infection in very low birthweight infants. Archives of Disease in Childhood. Fetal & Neonatal Edition 2009;94(1):F65-9.
16. Brion LP, Uko SE, Goldman DL. Risk of resistance associated with fluconazole prophylaxis: systematic review. Journal of Infection 2007;54(6):521-9.
17. Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics 2006;118(4):e1019-26.
18. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Archives of Disease in Childhood. Fetal and Neonatal Edition 2006;91(3):F188-92.
19. Clerihew L, McGuire W. Antifungal prophylaxis for very low birthweight infants: UK national survey. Archives of Disease in Childhood Fetal and Neonatal Edition 2008;93(3):F238-9.
20. Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr: National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006;118(2):717-22.
21. Ernst JA, Williams JM, Glick MR, Lemons JA. Osmolality of substances used in the intensive care nursery. Pediatrics 1983;72(3):347-52. [PUBMED: 6889039]
22. Faix RG, Kovarik SM, Shaw TR, Johnson RV. Mucocutaneous and invasive candidiasis among very low birth weight (<1, 500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 1989;83(1):101-7.
23. Frattarelli DA, Reed MD, Giacoia GP, Aranda JV. Antifungals in systemic neonatal candidiasis. Drugs 2004;64(9):949-68.
24. Friedman S, Richardson SE, Jacobs SE, O'Brien K. Systemic candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatric Infectious Disease Journal 2000;19(6):499-504.
25. Ganesan K, Harigopal S, Neal T, Yoxall CW. Prophylactic oral nystatin for preterm babies under 33 weeks gestation decreases fungal colonisation and invasive fungaemia. Archives of Disease in Childhood Fetal & Neonatal Edition 2009;94(4):F275-8.
26. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, et al.Members of the Vermont Oxford Network. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002;110(1 Pt 1):143-51.
27. Howell AJ, Isaacs D, Halliday R. Oral nystatin prophylaxis and neonatal fungal infections. Archives of Disease in Childhood. Fetal & Neonatal Edition 2009;94(6):F429-33.
28. Huang YC, Li CC, Lin TY, Lien RI, Chou YH, Wu JL, et al.Association of fungal colonization and invasive disease in very low birth weight infants. Pediatric Infectious Diseases Journal 1998;17(9):819-22.
29. Isaacs D. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?. Current Opinion in Infectious Diseases 2008;21(3):246-50.
30. Kaguelidou F, Pandolfini C, Manzoni P, Choonara I, Bonati M, Jacqz-Aigrain E. European survey on the use of prophylactic fluconazole in neonatal intensive care units. European Journal of Pediatrics 2012;171(3):439-45. [PUBMED: 21912893]
31. Karlowicz MG, Rowen JL, Barnes-Eley ML, Burke BL, Lawson ML, Bendel CM, et al.The role of birth weight and gestational age in distinguishing extremely low birth weight infants at high risk of developing candidemia from infants at low risk: a multicenter study. Pediatric Research 2002;51:301A.
32. Lee BE, Cheung PY, Robinson JL, Evanochko C, Robertson CM. Comparative study of mortality and morbidity in premature infants (birth weight < 1, 250g) with candidemia or candidal meningitis. Clinical Infectious Diseases 1998;27(3):559-65.
33. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109(1):34-9.
34. Manzoni P, Farina D, Leonessa M, d'Oulx EA, Galletto P, Mostert M, et al.Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006;118(6):2359-64.
35. O'Grady MJ, Dempsey EM. Antifungal prophylaxis for the prevention of neonatal candidiasis?. Acta Paediatrica 2008;97(4):430-3. [PUBMED: 18363952]
36. Pappu-Katikaneni LD, Rao KP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 1990;33(1):20-3.
37. Radmacher PG, Adamkin MD, Lewis ST, Adamkin DH. Milk as a vehicle for oral medications: hidden osmoles. Journal of Perinatology 2012;32(3):227-9. [PUBMED: 21701446]
38. The Nordic Cochrane Centre. The Cochrane Collabortion. Review Manager (Revman). 5.1. Copenhagan: The Nordic Cochrane Centre. The Cochrane Collabortion, 2011.
39. Rowen JL, Rench MA, Kozinetz CA, Adams JM, Baker CJ. Endotracheal colonization with candida enhances risk of systemic candidiasis in very low birth weight neonates. Journal of Pediatrics 1994;124(5 Pt 1):789-94.
40. Saiman L, Ludington BA, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al.Risk factors for candidemia in Neonatal Intensive Care Unit patients. The national epidemiology of mycosis survey study group. Pediatric Infectious Disease Journal 2000;19(4):319-24.
41. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al.Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91.
42. Austin NC, Darlow B. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003478.pub2]
43. Austin N, Darlow BA, McGuire W. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD003478.pub3]